Literature DB >> 26190830

A semi-blinded study comparing 2 methods of measuring nasal potential difference: Subcutaneous needle versus dermal abrasion.

E De Wachter1, I De Schutter2, A Meulemans3, R Buyl4, A Malfroot2.   

Abstract

BACKGROUND: According to European and US protocols, two nasal potential difference (NPD) measurement methods are considered acceptable, although they have not been formally compared: subcutaneous agar-filled needle with calomel (Ndl) and dermal abrasion with conducting cream and Ag/AgCl electrodes (Abr). We compared both in CF and healthy volunteers (HV), assessing their discriminative value and subject's preference.
METHODS: Twelve classic CF and 17 HV underwent both NPD methods, performed by one operator in random order. A written questionnaire, assessing preference, was completed after each test. Tracings were coded, scored in a semi-blinded fashion and categorised as CF/non-CF.
RESULTS: 110 tracings (56 Ndl/54 Abr) were collected: 42/110 scored CF and 68/110 non-CF, showing a good correlation. No significant preference for either method was reported.
CONCLUSION: Both NPD methods are similar in terms of discriminative value and subject's preference, comparing classical CF and HV. For diagnosing CF, the operator's preferred NPD-method may be used.
Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CF diagnosis; dermal abrasion method; nasal potential difference measurements; needle method

Mesh:

Substances:

Year:  2015        PMID: 26190830     DOI: 10.1016/j.jcf.2015.06.007

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  3 in total

1.  Chloride Conductance, Nasal Potential Difference and Cystic Fibrosis Pathophysiology.

Authors:  Elenara da Fonseca Andrade Procianoy; Fernando Antônio de Abreu E Silva; Paulo José Cauduro Maróstica; Paul M Quinton
Journal:  Lung       Date:  2019-11-16       Impact factor: 2.584

2.  What can the CF registry tell us about rare CFTR-mutations? A Belgian study.

Authors:  E De Wachter; M Thomas; S S Wanyama; S Seneca; A Malfroot
Journal:  Orphanet J Rare Dis       Date:  2017-08-22       Impact factor: 4.123

Review 3.  Assays of CFTR Function In Vitro, Ex Vivo and In Vivo.

Authors:  Anabela Santo Ramalho; Mieke Boon; Marijke Proesmans; François Vermeulen; Marianne S Carlon; Kris De Boeck
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.